Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Body and Mind Inc C.BAMM

Alternate Symbol(s):  BMMJ

Body and Mind Inc. is a Canada-based operations-focused cannabis company with active retail operations in Arkansas, Illinois and California, pending retail operations in New Jersey, and craft cultivation operations in Arkansas. The Company's segments include Wholesale, Retail and All others. The Company's products include flowers, pre rolls and hemp blunts, concentrates, carts and vapes, and edibles. Its featured products include Krispy Bites, Pretzel Bites and Chocolate Bites. It manages and operates a BaM Body and Mind branded dispensary. It owns and operates The Reef by Body and Mind retail dispensary in the limited license jurisdiction of Seaside, California. The Company's subsidiary is DEP Nevada Inc.


CSE:BAMM - Post by User

Post by chipper63on Feb 04, 2021 4:32pm
231 Views
Post# 32476330

Q1 FY2021 Financial Summary

Q1 FY2021 Financial Summary https://candlr.com/2021/02/02/body-and-mind-reports-q1-2021-financial-results-and-earnings-call/?fbclid=IwAR0pTMJEND53g1C0b7LQ4FnIGxBGLrDcdPmFMFOAWeDSF6vB0LxJ5JzH3kc

Q1 FY2021 Financial Summary (results expressed in $USD unless otherwise indicated):

  • Reported Q1 FY2021 revenue of $5.29 million, a 144% increase over Q4 FY2020 ($2.17 million) and 267 % increase over Q1 FY2020 ($1.44 million);
  • Q1 FY2021 Gross profit of $1.8 million;
  • Q1 FY2021 Net Operating Loss of $0.70 million;
  • Q1 FY2021 Net Loss of $0.78 million;
  • Basic and Diluted loss per share of $0.01;
  • Positive Adjusted EBITDA of $57,135*;
  • Managed Q1 FY2021 revenue of $6.49 million**;
  • Inventory of $1.87 million as of October 31, 2020;
  • At October 31, 2020, BaM had $1.33 million in cash and a working capital surplus of $1.91 million;
  • Total Assets were $40.57 million, Total Current Liabilities were $4.61 million and Total Liabilities were $7.19 million at October 31, 2020;
  • 108,307,278 common shares were issued and outstanding as of October 31, 2020 (108,377,778 as of January 25, 2021).

Operational Milestones for Q1 FY2021 and to Date:

California:

  • ShowGrow Long Beach dispensary ownership transferred to 100% owned Body and Mind subsidiary to allow consolidation of revenues effective August 28, 2020;
  • ShowGrow Long Beach dispensary commenced curbside pickup and online ordering purchase options;
  • ShowGrow San Diego dispensary has commenced delivery service in addition to curbside pickup and other on-line ordering purchase options.

Nevada:

  • Received cannabis distribution license from the state of Nevada;
  • Received approval to expand cultivation canopy. The Company continues to renovate past production areas into new cultivation space;
  • Worked with brand partner Her Highness to launch their female focused brand into the Las Vegas market.

Ohio:

  • Ownership of The Clubhouse dispensary outside Cleveland, Ohio transferred to a 100% owned Body and Mind subsidiary to allow consolidation of revenues effective September 4, 2020;
  • A definitive agreement is in place to acquire the remaining 70% ownership of NMG Ohio LLC subject to regulatory approval;
  • Development of the NMG Ohio production facility, which is currently 30% indirectly owned by BaM, has advanced with construction expected to be completed around March 2021.

Arkansas:

  • Body and Mind dispensary awarded “Best Dispensary in Arkansas” by Ark420.com;
  • Commenced delivery and online ordering options;
  • Preparation for cultivation ongoing with cultivation team engaged in the final stages of set up in advance of inspection and permitting by local and state authorities;
  • The facility construction Capex is complete with roughly 3,500 square feet of retail and approximately 6,500 square feet constructed for future cultivation and packaging operations.

“These strong quarterly results reflect our emphasis on lean operations and asset consolidation,” stated Michael Mills, CEO of BaM. “Our focus on limited license jurisdictions and efficient operations has resulted in strong financial results, a clean balance sheet and no long-term debt. As we fully consolidate our current assets and complete our current projects, we look forward to adding revenue within our current infrastructure. Our current production and cultivation developments are anticipated to expand the Body and Mind branded product portfolio into Ohio and Arkansas. Our dispensary and cultivation operations show steady growth as we continue to evaluate new expansion and acquisition opportunities for licenses and the Body and Mind brand.”

*Adjusted EBITDA is a Non-GAAP metric used by management that does not have any standardized meaning prescribed by U.S. GAAP and may not be comparable to similar measures presented by other companies. Management defines the Adjusted EBITDA as the Income (loss) from operations, as reported, before interest, taxes, and adjusted for removing other non-cash items, including the stock-based compensation expense, depreciation, and further adjustments to remove acquisition related costs or gains. Management believes Adjusted EBITDA is a useful financial metric to assess its operating performance on a cash adjusted basis before the impact of non-cash items and acquisition activities. The most comparable financial measure calculated and presented in accordance with U.S. GAAP is net income (loss) from operations, which was presented above prior to the Adjusted EBITDA figure.

**Managed revenue: refers to results for the full three months ended October 31, 2020, including managed revenues, which are sales of cannabis products from entities for which management arrangements or definitive agreements are in place but BaM cannot consolidate due to regulatory restrictions, or from equity investments, in which results cannot be consolidated. Managed entities include Body and Mind’s involvement in certain California, Ohio, and Arkansas operations.

The unaudited consolidated interim financial statements for the quarter ended October 31, 2020 are available on SEDAR and EDGAR and should be read in connection with this news release.

<< Previous
Bullboard Posts
Next >>